Similar articles

• [Genetic control by the HLA region of the immune response to factor VIII in hemophilic patients].

  Nuñez-Roldan A, Arnaiz-Villena A, Nuñez-Ollero G. Nuñez-Roldan A, et al. C R Seances Acad Sci D. 1979 Jun 25;288(23):1719-20. C R Seances Acad Sci D. 1979. PMID: 114335 French.
• Relationship of major histocompatibility complex class II genes to inhibitor antibody formation in hemophilia A.

  Lippert LE, Fisher LM, Schook LB. Lippert LE, et al. Thromb Haemost. 1990 Dec 28;64(4):564-8. Thromb Haemost. 1990. PMID: 1982196
• Porcine factor VIII: preparation and use in treatment of inhibitor patients.

  Kernoff PB. Kernoff PB. Prog Clin Biol Res. 1984;150:207-24. Prog Clin Biol Res. 1984. PMID: 6431429 Clinical Trial. No abstract available.
• [Molecular pathogenesis of haemophilia A].

  Habart D. Habart D. Cas Lek Cesk. 2005;144(11):727-32. Cas Lek Cesk. 2005. PMID: 16335697 Review. Czech.
• The role of genetics in inhibitor formation.

  Gill JC. Gill JC. Thromb Haemost. 1999 Aug;82(2):500-4. Thromb Haemost. 1999. PMID: 10605742 Review.